The Feasibility of the PAINReportIt Guided Relaxation Intervention-Outpatient

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-04-30

Study Completion Date

2017-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Our goal is to improve the self-management of pain and stress in adult outpatients with sickle cell disease (SCD) by determining the feasibility of a self-managed guided relaxation (GR) stress reduction intervention using a tablet-based mobile device. Currently, opioid analgesics are primarily used to treat SCD pain while self-managed behavioral modalities such as GR, are rarely used. Little is known about the effects or mechanisms of GR on pain and stress, in adults with SCD. Emerging evidence from the hypothalamic pituitary adrenal (HPA) axis theory offer insights for understanding the mechanisms. Adding GR as a supplement to analgesic therapies will address the paucity of self-management strategies for controlling pain in SCD. GR is a simple and cost-effective non-drug intervention that could reduce pain and stress in outpatients with SCD. GR is an intervention where outpatients with SCD are directed to listen to and view audio-visual recordings while they visualize themselves being immersed in that scene.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Feasibility of the PAINReportIt Guided Relaxation Intervention-INPATIENT

NCT02729350

Sickle Cell Disease Stress Pain

COMPLETED NA

Hypnosis to Manage Pain and Symptoms in Patients With Sickle Cell Disease

NCT00393250

Sickle Cell Disease Pain Management

COMPLETED PHASE3

Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain

NCT04906447

Sickle Cell Disease

ACTIVE_NOT_RECRUITING PHASE2

Pilot Study: Relaxation and Guided Imagery in Hispanic Persons Diagnosed With Fibromyalgia

NCT00512590

Fibromyalgia Pain Functional Status +2 more

COMPLETED NA

Web-based Education to Enhance Fibromyalgia Management

NCT00423631

Fibromyalgia Fibrositis

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigator will recruit adult outpatients with sickle cell disease (SCD) from the University of Florida Health Hematology Clinics and conduct study visits in a research room located at the College of nursing.

The investigator will stratify participants on worst pain intensity (\<=5 and \>5) and randomly assign 15 adults to attention control (stress/pain tracking; 12-min SCD experience discussion) and 15 adults to experimental (stress/pain tracking; 12-min GR video clip) groups.

The immediate intervention effects will be examined for pain (primary) and stress (secondary) outcomes. Vital signs for determining relaxation responses (mediators) will be collected immediately before and after the 12-min interventions.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sickle Cell Disease Stress Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Guided Relaxation video clip

This intervention is a 12-minute guided audio-visual relaxation intervention delivered at the baseline visit to determine the immediate effects of guided relaxation intervention on stress and pain in outpatients with sickle cell disease.

Group Type EXPERIMENTAL

Guided Relaxation video clip

Intervention Type BEHAVIORAL

This intervention is a 12-minute guided audio-visual relaxation intervention.

Sickle cell experience discussion

Attention Control Group: This intervention is a 12-minute sickle cell disease experience discussion. In this computer-based discussion, patients talk about their sickle cell disease experience. The audio-taped questions and onscreen directions were programmed for self-administration. Subjects' responses will be captured via the microphone so that Data Collectors are not involved in this discussion process, and it is equivalent to the guided relaxation activity.

Group Type OTHER

Sickle Cell Disease Experience Discussion

Intervention Type BEHAVIORAL

This intervention is a 12-minute computer-administered sickle cell disease experience discussion.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Guided Relaxation video clip

This intervention is a 12-minute guided audio-visual relaxation intervention.

Intervention Type BEHAVIORAL

Sickle Cell Disease Experience Discussion

This intervention is a 12-minute computer-administered sickle cell disease experience discussion.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Has SCD diagnosis;
* Reports pain 3 or greater in the previous 24 hours (0-10 scale)
* Receives care at the University of Florida (UF) Health/Shands
* Speaks and reads English
* 18 years of age or older
* Self-identifies as being of African or Hispanic descent